AMGEN PRESENTS NEW REPATHA® (EVOLOCUMAB) DATA AT AHA 2022
Very low LDL-C Levels Data Reinforces Long-Term Efficacy and Consistent Safety Profile of Repatha Observed in FOURIER-OLE THOUSAND OAKS, Calif., N...
Puerto Rico United States Michael Strapazon Jessica Akopyan Amgen Medinfo American Heart Association Scientific Sessions
Source: businessinsider.com